NeuroLight Inc developed a prototype of the sleep mask that uses light and sound for brain entrainment to improve sleep quality.


Summary: NeuroLight Inc has completed its phase I National Science Foundation Small Business Innovation Research grant, advancing the development of NeuroMask, a neuromodulation sleep mask designed to improve sleep quality and treat insomnia. The company has made progress, including developing an alpha prototype and establishing the technical foundation for the next-generation device. NeuroLight plans to apply for a phase II grant to further refine the device and seek FDA clearance.

Key Takeaways:

  • Completion of Phase I Grant: NeuroLight completed its phase I National Science Foundation Small Business Innovation Research grant, marking advancements in the development of the NeuroMask device.
  • Key Achievements: The company extracted unique cortical signatures related to sleep stages, developed an alpha prototype of NeuroMask, and laid the groundwork for a next-generation sleep modulation device.
  • Future Plans: NeuroLight intends to apply for a phase II grant to refine the NeuroMask design, conduct proof-of-concept studies, and pursue FDA clearance as a medical device for treating insomnia.

NeuroLight Inc, a neuroscience-based research and development company, has completed its phase I National Science Foundation Small Business Innovation Research grant, marking progress in developing the NeuroMask, a neuromodulation sleep mask aimed at improving sleep quality and addressing insomnia.

The company has submitted its outcomes report. Key achievements include: 

  • Extracted and analyzed unique cortical signatures associated with sleep stages and transitions, including discovering previously unknown brainwave patterns associated with stage transitions.
  • Developed alpha prototype of NeuroMask, a sleep mask that uses light and sound for brain entrainment.
  • Established the technical foundation for a next-generation sleep modulation device.

“Our phase I study has demonstrated the feasibility of NeuroMask, a novel approach to improving sleep health,” says Alexander Poltorak, president and founder of NeuroLight, in a release. “By leveraging the power of brain entrainment technology, we are opening new avenues for non-invasive, drug-free sleep therapy.”

Building on this success, NeuroLight plans to apply for a phase II National Science Foundation Small Business Innovation Research grant to further advance the development of NeuroMask. The company aims to refine the device design, conduct a proof-of-concept sleep study, and pursue US Food and Drug Administration clearance as a medical device for treating insomnia.

The company’s approach is supported by several US patents

Photo caption: NeuroMask

Photo credit: NeuroLight Inc